Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Mendelian Genomics, |
RCV001196887 | SCV001367521 | uncertain significance | Homocystinuria due to methylene tetrahydrofolate reductase deficiency | 2019-02-20 | criteria provided, single submitter | clinical testing | This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PP2. |
Ambry Genetics | RCV003293987 | SCV003997091 | uncertain significance | Inborn genetic diseases | 2023-05-27 | criteria provided, single submitter | clinical testing | The p.A524E variant (also known as c.1571C>A), located in coding exon 9 of the MTHFR gene, results from a C to A substitution at nucleotide position 1571. The alanine at codon 524 is replaced by glutamic acid, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |